Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07ULI
|
|||
| Drug Name |
PMID27215781-Compound-25
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
ISIS INNOVATION LIMITED
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H14N4S
|
|||
| Canonical SMILES |
CCCCSC1=NC2=C(C3=CC=CC=C3N2)N=N1
|
|||
| InChI |
1S/C13H14N4S/c1-2-3-8-18-13-15-12-11(16-17-13)9-6-4-5-7-10(9)14-12/h4-7H,2-3,8H2,1H3,(H,14,15,17)
|
|||
| InChIKey |
JLINGBANGFPKNS-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cannabinoid receptor 2 (CB2) | Target Info | Agonist | [1] |
| Target's Patent Info | Cannabinoid receptor 2 (CB2) | Target's Patent Info | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Class A/1 (Rhodopsin-like receptors) | |||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Small Ligand GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update.Expert Opin Ther Pat. 2016 Jul;26(7):843-56. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.